Breast cancer cells themselves also express HMGCS2, where the enzyme is associated with resistance to endocrine therapy with tamoxifen, but the mechanism underlying the link between HMGCS2 and tamoxifen resistance seems to be related to changes in mitochondrial oxidative stress [155]. This evidence concerns the gene HMGCS2 and breast carcinoma.